Gallizzi Romina, Pidone Caterina, Cantarini Luca, Finetti Martina, Cattalini Marco, Filocamo Giovanni, Insalaco Antonella, Rigante Donato, Consolini Rita, Maggio Maria Cristina, Civino Adele, Martino Silvana, Olivieri Alma Nunzia, Fabio Giovanna, Pastore Serena, Mauro Angela, Sutera Diana, Trimarchi Giuseppe, Ruperto Nicolino, Gattorno Marco, Cimaz Rolando
Unit of Pediatrics, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Rheumatology Unit Policlinico "Le Scotte", University of Siena, Siena, Italy.
Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84. doi: 10.1186/s12969-017-0213-x.
Behçet's disease is a rare multi-systemic inflammatory disease with unknown etiology which involves principally oral and genital mucosa, skin and eyes. Average age at onset of the disease is about 25-30 years, but it may be diagnosed before the age of 16. It is not very rare in Italy, even though there are limited data concerning epidemiology. Aim of this study is to describe the baseline data of an Italian cohort of patients with as having BD or probable BD.
We described the baseline data of the first national epidemiological study on children coming from 16 Italian Pediatric Rheumatologic Centers diagnosed by the treating physicians as having Behçet's Disease. Data on demographic characteristics, clinical features and therapy were collected. We then compared our findings to those of international pediatric cohort studies and also retrospectively evaluated the ability to diagnose BD using ISG, ICBD and, for the first time, the new PEDBD criteria.
The study included 110 patients (62 M, 48F). Average age at onset was 8.34±4.11 years. The frequencies of signs/symptoms were: recurrent oral aphtosis 94.5%, genital ulcers 33.6%, ocular 43.6%, gastrointestinal 42.7%, musculoskeletal 42.7%, neurological 30.9% and vascular involvement 10%. Thirty-two patients (29.1%) fulfilled ISG, 78 (70.9%) ICBD, 50 (45.5%) PEDBD criteria and 31 (28%) didn't fulfill any of them. The most frequently used treatments were colchicine and corticosteroids followed by immunosuppressants. Four patients received biologic therapy (anti TNF-α and anti-IL-1) to treat severe organ involvement.
Recurrent oral aphtosis was the most frequent clinical manifestation, followed by ocular involvement. Gastrointestinal lesions were more frequent in Italy than in non-European countries as opposed to genital ulcers. Skin, ocular and vascular manifestations had a higher frequency in males and genital ulcers in females. Constitutional symptoms were present in 44.5% and recurrent fever in one third of our population.
白塞病是一种病因不明的罕见多系统炎症性疾病,主要累及口腔和生殖器黏膜、皮肤及眼睛。该病的平均发病年龄约为25 - 30岁,但也可能在16岁之前被诊断出来。在意大利,该病并非十分罕见,尽管关于流行病学的数据有限。本研究的目的是描述一组意大利白塞病或疑似白塞病患者的基线数据。
我们描述了来自16个意大利儿科风湿病中心的儿童患者的基线数据,这些儿童由主治医生诊断为患有白塞病。收集了人口统计学特征、临床特征及治疗方面的数据。然后我们将研究结果与国际儿科队列研究的结果进行比较,并首次回顾性评估使用国际白塞病研究组(ISG)、国际白塞病分类标准(ICBD)以及新的儿科白塞病标准(PEDBD)诊断白塞病的能力。
该研究纳入了110例患者(62例男性,48例女性)。平均发病年龄为8.34±4.11岁。体征/症状的出现频率分别为:复发性口腔溃疡94.5%,生殖器溃疡33.6%,眼部病变43.6%,胃肠道病变42.7%,肌肉骨骼病变42.7%,神经病变30.9%,血管受累10%。32例患者(29.1%)符合ISG标准,78例(70.9%)符合ICBD标准,50例(45.5%)符合PEDBD标准,31例(28%)不符合任何一项标准。最常用的治疗方法是秋水仙碱和皮质类固醇,其次是免疫抑制剂。4例患者接受生物治疗(抗TNF-α和抗IL-1)以治疗严重的器官受累。
复发性口腔溃疡是最常见的临床表现,其次是眼部受累。与生殖器溃疡相比,意大利的胃肠道病变比非欧洲国家更为常见。皮肤、眼部和血管表现男性更为常见,生殖器溃疡女性更为常见。44.5%的患者有全身症状,三分之一的患者有反复发热。